1. Home
  2. CNTB vs GLST Comparison

CNTB vs GLST Comparison

Compare CNTB & GLST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • GLST
  • Stock Information
  • Founded
  • CNTB 2012
  • GLST 2019
  • Country
  • CNTB United States
  • GLST United States
  • Employees
  • CNTB N/A
  • GLST N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • GLST Consumer Electronics/Appliances
  • Sector
  • CNTB Health Care
  • GLST Industrials
  • Exchange
  • CNTB Nasdaq
  • GLST Nasdaq
  • Market Cap
  • CNTB 55.2M
  • GLST 48.0M
  • IPO Year
  • CNTB 2021
  • GLST 2022
  • Fundamental
  • Price
  • CNTB $0.81
  • GLST $6.56
  • Analyst Decision
  • CNTB Strong Buy
  • GLST
  • Analyst Count
  • CNTB 1
  • GLST 0
  • Target Price
  • CNTB $8.00
  • GLST N/A
  • AVG Volume (30 Days)
  • CNTB 18.3K
  • GLST 19.9K
  • Earning Date
  • CNTB 04-15-2025
  • GLST 01-01-0001
  • Dividend Yield
  • CNTB N/A
  • GLST N/A
  • EPS Growth
  • CNTB N/A
  • GLST N/A
  • EPS
  • CNTB N/A
  • GLST N/A
  • Revenue
  • CNTB $24,116,000.00
  • GLST N/A
  • Revenue This Year
  • CNTB N/A
  • GLST N/A
  • Revenue Next Year
  • CNTB $62.09
  • GLST N/A
  • P/E Ratio
  • CNTB N/A
  • GLST N/A
  • Revenue Growth
  • CNTB N/A
  • GLST N/A
  • 52 Week Low
  • CNTB $0.77
  • GLST $4.68
  • 52 Week High
  • CNTB $2.66
  • GLST $20.89
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 39.94
  • GLST 42.78
  • Support Level
  • CNTB $0.79
  • GLST $5.62
  • Resistance Level
  • CNTB $0.91
  • GLST $9.79
  • Average True Range (ATR)
  • CNTB 0.08
  • GLST 1.64
  • MACD
  • CNTB -0.00
  • GLST 0.05
  • Stochastic Oscillator
  • CNTB 26.15
  • GLST 29.79

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About GLST Global Star Acquisition Inc.

Global Star Acquisition Inc is a blank check company.

Share on Social Networks: